The Net Margin of Ocumension Therapeutics (1477.HK) is -64.29%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -64.29% |
2023-12-31 | -154.15% |
2022-12-31 | -253.30% |
2021-12-31 | -463.06% |
2020-12-31 | -17294.33% |
2019-12-31 | -690690.00% |
2018-12-31 | -690690.00% |